USPTO serial 79444513
CRYONOID
Reviewed by CopyMark Law Group
Status 681
- Filing date
- Status date
- Registration date
- —
- Examiner
- MCCARTHY, JOSEPH PATRICK
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CRYONOID?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Kimberly A Peaslee
Kimberly A Peaslee Fasken Martineau DuMoulin LLP800 Place Victoria, Bureau 3500c/o Kimberly PeasleeMontreal, QC, H3C 0B4Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | medical preparations for the treatment of cancer, infectious diseases, inflammatory diseases, immune system disorders and hematological disorders; pharmaceuticals for the treatment of cancer, infectious diseases, inflammatory diseases, immune system disorders and hematological disorders; chemical preparations for medical purposes, namely, for cancer, infectious diseases, inflammatory diseases, immune system disorders and hematological disorders; chemical preparations for pharmaceutical purposes, namely, for cancer, infectious diseases, inflammatory diseases, immune system disorders and hematological disorders; chemical reagents for medical use; cell growth media for growing cells for medical use; stem cells for medical use; stem cells for medical purposes; cells for medical use; cells for use in medical analysis; pharmaceutical preparations for cellular therapy for the treatment of cancer, infectious diseases, inflammatory diseases, immune system disorders and hematological disorders; diagnostic preparations for medical purposes | ACTIVE | — |
| 042 | scientific and technological services and research and design relating thereto in the field of stem cell technology, cell and gene therapy, regenerative medicine, immunology and cellular biomanufacturing; medical research; scientific laboratory services; research and development in the field of cells; scientific services relating to the isolation and cultivation of human tissues and cells | ACTIVE | — |
| 044 | medical services; human hygiene and beauty care services; health counselling; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical treatment using cultured cells; medical services relating to the removal, treatment and processing of human cells; hormone replacement therapy services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 14, 2026 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Oct 14, 2026 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Oct 1, 2026 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 28, 2026 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 28, 2026 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Sep 28, 2026 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Aug 6, 2026 | RFNT | REFUSAL PROCESSED BY IB | — |
| Jul 16, 2026 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Jul 16, 2026 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 29, 2026 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 28, 2026 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 26, 2026 | DOCK | ASSIGNED TO EXAMINER | — |
| Feb 27, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Feb 27, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Feb 26, 2026 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |